Cite
HARVARD Citation
Suzuki, T. et al. (2021). Clinicopathological analysis of primary refractory diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy. Cancer medicine. pp. 5101-5109. [Online].